Cyclophosphamide dose intensification during induction therapy for intermediate-risk pediatric rhabdomyosarcoma is feasible but does not improve outcome: A report from the soft tissue sarcoma committee of the children's oncology group

Sheri L. Spunt, Lynette M. Smith, Frederick B. Ruymann, Stephen J. Qualman, Sarah S. Donaldson, David A. Rodeberg, James R. Anderson, William M. Crist, Michael P. Link

Research output: Contribution to journalArticlepeer-review

48 Scopus citations

Fingerprint

Dive into the research topics of 'Cyclophosphamide dose intensification during induction therapy for intermediate-risk pediatric rhabdomyosarcoma is feasible but does not improve outcome: A report from the soft tissue sarcoma committee of the children's oncology group'. Together they form a unique fingerprint.

Medicine & Life Sciences